Sunday, August 9, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Apple’s Upcoming Earnings: A Crucial Test for the Tech Giant

Robert Sasse by Robert Sasse
January 24, 2026
in Analysis, Earnings, Nasdaq, Tech & Software, Trading & Momentum
0
Apple Stock
0
SHARES
27
VIEWS
Share on FacebookShare on Twitter

As Apple approaches the release of its quarterly financial results, a palpable sense of unease has settled over the markets. Despite a foundation of robust fundamentals, investors have been taking profits in recent weeks, driving the share price into a clear downward trend. The central question now is whether the company can meet the elevated expectations for the current quarter or if the recent period of weakness will extend further.

High Stakes and Lofty Expectations

The upcoming report, due after the U.S. market close on January 29, is set against a backdrop of significant investor anticipation. For the first quarter of fiscal 2026, consensus estimates point to earnings per share of $2.65, which would represent an approximate 10% increase year-over-year. Looking further ahead, analysts project full-year fiscal 2026 EPS of $8.15, a 9% rise, with another jump to $9.10 expected for 2027. These figures indicate that the market has already priced in substantial growth.

This pressure comes even after Apple posted convincing results in its previous quarter. For Q4 of fiscal 2025, the company delivered a clear beat:
* Earnings per share came in at $1.85, roughly 6% above the consensus estimate of $1.73.
* Revenue climbed to $102.5 billion, surpassing the targeted $101.2 billion.
* iPhone revenue increased by 6% to $49.03 billion.
* The installed base of active devices reached record levels across all product categories.

Diverging Analyst Views on the Pullback

The stock’s performance has been under pressure, shedding about 2.4% over the past week and nearly 9% over the last 30 days. It currently trades roughly 9% below its 52-week high, though it remains well above the annual low. This correction appears driven more by profit-taking and heightened expectations for the upcoming report than by any fundamental breakdown in the business.

Market experts are divided on what this weakness signifies. Goldman Sachs analyst Michael Ng views the decline as a potential entry point. He forecasts a significant iPhone surge for Q1 2026, anticipating:
* A 13% year-over-year increase in iPhone revenue.
* A 5% rise in unit shipments.
* A dramatic 26% revenue jump in China, following Apple’s recapture of the top smartphone market position there.

Goldman also cites potential tailwinds from product and cycle changes, including future growth from a planned iPhone Fold and a potential two-year iPhone release rhythm that could structure demand more predictably.

Should investors sell immediately? Or is it worth buying Apple?

In contrast, Morningstar maintains a more measured stance, assigning the stock three out of five stars. Their long-term fair value estimate sits at $240 per share—close to current levels—leading them to label the equity as “fairly valued,” neither significantly under- nor overpriced. They project an average annual revenue growth rate of 7% through fiscal 2030, with the iPhone remaining the core profit driver. Fiscal 2026, in particular, is expected to benefit from higher prices across the iPhone lineup and a strong upgrade cycle centered on the anticipated iPhone 17 generation.

Artificial Intelligence: A New Chapter with Google

A key narrative for Apple is its push into artificial intelligence, an area where it has faced criticism for lagging behind rivals. The recently announced partnership with Google aims to address this gap. The collaboration will see a new version of Siri powered by Google’s Gemini technology. Market observers estimate the annual value of this deal to be around $1 billion, with the goal of significantly enhancing the voice assistant’s capabilities and visibly upgrading Apple’s AI profile.

Morningstar expects Apple to address this topic explicitly in the upcoming earnings conference call, viewing the partnership as a critical step to avoid falling further behind in the AI race.

The Path Forward

With a recent closing price of $249.36, the shares reflect both the recent consolidation and a continued premium above the 200-day moving average. The immediate future will be shaped by key events:
* January 29: Q1 FY 2026 earnings release after the U.S. market close.
* January 29: Conference call with CEO Tim Cook and CFO Kevan Parekh at 5:00 p.m. Eastern Time.
* February 24: The 2026 Annual General Meeting, to be held virtually.

The ultimate driver will be whether Apple, on January 29, can confirm its ambitious profit and growth targets, thereby reinforcing confidence in its revenue dynamics, iPhone pipeline, and nascent AI strategy.

Ad

Apple Stock: Buy or Sell?! New Apple Analysis from August 8 delivers the answer:

The latest Apple figures speak for themselves: Urgent action needed for Apple investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 8.

Apple: Buy or sell? Read more here...

Tags: Apple
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Nvidia Stock
AI & Quantum Computing

Nvidia’s Latest Surge Is About More Than a Single Order

August 8, 2026
Plug Power Stock
Earnings

Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

August 8, 2026
Petrobras Stock
Chemicals

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

August 8, 2026
Next Post
Uranium Energy Stock

Uranium Energy Stock Pulls Back as Investors Secure Profits

DeFi Technologies Stock

DeFi Technologies Faces Mounting Legal and Market Pressures

Axsome Stock

Axsome Therapeutics: Pipeline Momentum Fuels Investor Confidence

Recommended

Biotechnology Stock Bull Market

Analyst Reiterates Buy Rating and 12 Price Target for Shattuck Labs Citing Promising Potential in Biotech Sector

2 years ago
Sangamo Therapeutics Stock

A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

7 months ago
Diginex Stock

Leadership Shift at Diginex as ESG Software Founder Takes Helm

6 months ago
Novo Nordisk Stock

Novo Nordisk’s Bold Gambit: Price Cuts and Restructuring Amid Market Pressure

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

Amazon’s Three-Trillion-Dollar Moment: A Founder’s Exit, a $220 Billion Wager, and the Fine Print Behind the Record Numbers

The AI Payoff Shifts: Airbnb, SpaceX, and Crypto Show Their Hand

Trending

Novo Nordisk Stock
European Markets

Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline

by SiterGedge
August 8, 2026
0

Novo Nordisk is getting one piece of good news that is easy to count: Wegovy has now...

Nvidia Stock

Nvidia’s Latest Surge Is About More Than a Single Order

August 8, 2026
Plug Power Stock

Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

August 8, 2026
Petrobras Stock

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

August 8, 2026
FALLBACK Stock

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

August 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline
  • Nvidia’s Latest Surge Is About More Than a Single Order
  • Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com